Lodo Therapeutics

Developer novel therapeutics to treat resistant infectious diseases and cancers using AI

placeNew York City, New York, United States calendar_todayFounded 2015 groups24 employees language lodotherapeutics.com

Registered entities

Innovation

2 patent families — focus: Physics & computing, Chemistry & metallurgy; filing pace slowing. Cited 16 times.

YearFilings
20211
20221
20231
20241

Investor mix

13 investors on record.

Investor typeCountShare
Venture capital431%
Angel & family office18%
Other / undisclosed862%
Coming soon